drug

nirogacestat

1 story · latest Nov 6, 2026

Follow nirogacestat. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved Nov 2023 · NDA217677
Brand: Ogsiveo
Code: PF-03084014
Trials: 1 registered trial in coverage

Timeline

FDA approved nirogacestat for desmoid tumors in November 2023

Nov 6Regulatory decisionnirogacestat

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.